Syndecan 4-c-ros oncogene 1 fusion as a mechanism of acquired resistance in epidermal growth factor receptor mutant lung adenocarcinoma

por Zhu, You-Cai, Xu, Chun-Wei, Zhang, Qu-Xia, Wang, Wen-Xian, Lei, Lei, Zhuang, Wu
Publicado 2019

Clonally‐related primary ALK rearranged adenocarcinoma and associated metastatic lesions

por Zhu, You‐cai, Deng, Yun‐te, Wang, Wen‐xian, Xu, Chun‐wei, Zhuang, Wu, Du, Kai‐qi
Publicado 2018

CEP72‐ROS1: A novel ROS1 oncogenic fusion variant in lung adenocarcinoma identified by next‐generation sequencing

por Zhu, You‐cai, Zhou, Yue‐fen, Wang, Wen‐xian, Xu, Chun‐wei, Zhuang, Wu, Du, Kai‐qi, Chen, Gang
Publicado 2018

Dual drive coexistence of EML4‐ALK and TPM3‐ROS1 fusion in advanced lung adenocarcinoma

por Zhu, You‐cai, Liao, Xing‐hui, Wang, Wen‐xian, Xu, Chun‐wei, Zhuang, Wu, Wei, Jian‐guo, Du, Kai‐qi
Publicado 2017

Eye metastasis in lung adenocarcinoma mimicking anterior scleritis: A case report

por Chen, Hua-Fei, Wang, Wen-Xian, Li, Xiao-Feng, Wu, Li-Xin, Zhu, You-Cai, Du, Kai-Qi, Xu, Chun-Wei
Publicado 2020

Hemangioma of the Rib: A Rare Case Report and Literature Review

por Zhu, You-cai, Lin, Xue-ping, Lu, Yan, Wang, Wen-xian, Du, Kai-qi, Ye, Xiao-qian, Zong, Chong, Xu, Chun-wei
Publicado 2017

Lung cancer with concurrent EGFR mutation and ROS1 rearrangement: a case report and review of the literature

por Zhu, You-cai, Xu, Chun-wei, Ye, Xiao-qian, Yin, Man-xiang, Zhang, Jin-xian, Du, Kai-qi, Zhang, Zhi-hao, Hu, Jian
Publicado 2016

A prostate cancer patient with isolated lung metastases: a case report

por Wu, Li-Xin, Lei, Lei, Zhu, You-Cai, Du, Kai-Qi, Li, Xiao-Feng, Chen, Hua-Fei, Wang, Wen-Xian, Xu, Chun-Wei
Publicado 2020

Intestinal metastasis from primary ROS1-positive lung adenocarcinoma cancer patients responding to crizotinib

por Chen, Hua-fei, Zhang, Qu-xia, Zhu, You-cai, Du, Kai-qi, Li, Xiao-feng, Wu, Li-xin, Wang, Wen-xian, Xu, Chun-wei
Publicado 2018

A novel co-existing ZCCHC8-ROS1 and de-novo MET amplification dual driver in advanced lung adenocarcinoma with a good response to crizotinib

por Zhu, You-cai, Wang, Wen-xian, Xu, Chun-wei, Zhuang, Wu, Song, Zheng-bo, Du, Kai-qi, Chen, Gang, Lv, Tang-feng, Song, Yong
Publicado 2018

Dual drive coexistence of ALK rearrangement and KRAS mutation advanced lung adenocarcinoma and response to crizotinib

por Zhu, You-Cai, Wan, Bing, Wu, Li-Xin, Li, Xing-Liang, Wang, Wen-Xian, Xu, Chun-Wei, Zhuang, Wu, Wei, Jian-Guo, Du, Kai-Qi
Publicado 2019

Patients harboring ALK rearrangement adenocarcinoma after acquired resistance to crizotinib and transformation to small-cell lung cancer: a case report

por Zhu, You-cai, Liao, Xing-hui, Wang, Wen-xian, Xu, Chun-wei, Zhuang, Wu, Zhong, Li-hua, Du, Kai-qi, Chen, Yan-ping, Chen, Gang, Fang, Mei-yu
Publicado 2017

Association between BRAF mutant classification and the efficacy of pemetrexed-based chemotherapy in Chinese advanced non-small cell lung cancer patients: a multicenter retrospectiv...

por Lei, Lei, Wang, Wen-Xian, Zhu, You-Cai, Pu, Xing-Xiang, Fang, Yong, Wang, Hong, Zhuang, Wu, Zhang, Yin-Bin, Wang, Li-Ping, Xu, Chun-Wei, Fang, Mei-Yu
Publicado 2020

Comparison of the c‐MET gene amplification between primary tumor and metastatic lymph nodes in non‐small cell lung cancer

por Xu, Chun‐wei, Wang, Wen‐xian, Wu, Mei‐juan, Zhu, You‐cai, Zhuang, Wu, Lin, Gen, Du, Kai‐qi, Huang, Yun‐jian, Chen, Yan‐ping, Chen, Gang, Fang, Mei‐yu
Publicado 2017

Patient harboring a novel PIK3CA point mutation after acquired resistance to crizotinib in an adenocarcinoma with ROS1 rearrangement: A case report and literature review

por Xu, Chun‐wei, Wang, Wen‐xian, Huang, Rong‐fang, He, Cheng, Liao, Xing‐hui, Zhu, You‐cai, Du, Kai‐qi, Zhuang, Wu, Chen, Yan‐ping, Chen, Gang, Fang, Mei‐yu
Publicado 2017

Concurrent ROS1 gene rearrangement and KRAS mutation in lung adenocarcinoma: A case report and literature review

por Zhu, You‐cai, Lin, Xue‐ping, Li, Xiao‐feng, Wu, Li‐xin, Chen, Hua‐fei, Wang, Wen‐xian, Xu, Chun‐wei, Shen, Jian‐fa, Wei, Jian‐guo, Du, Kai‐qi
Publicado 2017

A real-world study in advanced non-small cell lung cancer with de novo brain metastasis

por Lei, Lei, Wang, Wen-xian, Wang, Dong, Lin, Li, Zhu, You-cai, Wang, Hong, Wang, Li-ping, Zhuang, Wu, Fang, Mei-yu, Wan, Bing, Feng, Hui-jing, Xu, Chun-wei
Publicado 2021

Molecular Characteristics and Clinical Outcomes of EGFR Exon 19 C-Helix Deletion in Non–Small Cell Lung Cancer and Response to EGFR TKIs

por Xu, Chun-wei, Lei, Lei, Wang, Wen-xian, Lin, Li, Zhu, You-cai, Wang, Hong, Miao, Li-yun, Wang, Li-ping, Zhuang, Wu, Fang, Mei-yu, Lv, Tang-feng, Song, Yong
Publicado 2020

Effect of icotinib on advanced lung adenocarcinoma patients with sensitive EGFR mutation detected in ctDNA by ddPCR

por Chen, Hua-Fei, Lei, Lei, Wu, Li-Xin, Li, Xiao-Feng, Zhang, Qu-Xia, Pan, Wei-Wei, Min, Yong-Hua, Zhu, You-Cai, Du, Kai-Qi, Wang, Min, Wang, Wen-Xian, Xu, Chun-Wei
Publicado 2019

Real‐world efficacy and potential mechanism of resistance of icotinib in Asian advanced non‐small cell lung cancer with EGFR uncommon mutations: A multi‐center study

por Lei, Lei, Wang, Wen‐xian, Zhu, You‐cai, Li, Jin‐luan, Fang, Yong, Wang, Hong, Zhuang, Wu, Zhang, Yin‐bin, Wang, Li‐ping, Fang, Mei‐yu, Xu, Chun‐wei, Wang, Xiao‐jia, Lv, Tang‐feng, Song, Yong
Publicado 2019